241 related articles for article (PubMed ID: 16300848)
1. Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92.
Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Dieckmann K; Meisner C; Bamberg M
Radiother Oncol; 2005 Dec; 77(3):278-85. PubMed ID: 16300848
[TBL] [Abstract][Full Text] [Related]
2. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials.
Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Meisner C; Pietsch T; Deinlein F; Urban C; Warmuth-Metz M; Bamberg M
J Clin Oncol; 2006 Apr; 24(10):1554-60. PubMed ID: 16575007
[TBL] [Abstract][Full Text] [Related]
3. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
Massimino M; Gandola L; Giangaspero F; Sandri A; Valagussa P; Perilongo G; Garrè ML; Ricardi U; Forni M; Genitori L; Scarzello G; Spreafico F; Barra S; Mascarin M; Pollo B; Gardiman M; Cama A; Navarria P; Brisigotti M; Collini P; Balter R; Fidani P; Stefanelli M; Burnelli R; Potepan P; Podda M; Sotti G; Madon E;
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1336-45. PubMed ID: 15050308
[TBL] [Abstract][Full Text] [Related]
5. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
6. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
[TBL] [Abstract][Full Text] [Related]
7. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Needle MN; Goldwein JW; Grass J; Cnaan A; Bergman I; Molloy P; Sutton L; Zhao H; Garvin JH; Phillips PC
Cancer; 1997 Jul; 80(2):341-7. PubMed ID: 9217048
[TBL] [Abstract][Full Text] [Related]
9. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.
Benesch M; Weber-Mzell D; Gerber NU; von Hoff K; Deinlein F; Krauss J; Warmuth-Metz M; Kortmann RD; Pietsch T; Driever PH; Quehenberger F; Urban C; Rutkowski S
J Neurosurg Pediatr; 2010 Aug; 6(2):137-44. PubMed ID: 20672934
[TBL] [Abstract][Full Text] [Related]
10. Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment.
Massimino M; Giangaspero F; Garrè ML; Genitori L; Perilongo G; Collini P; Riva D; Valentini L; Scarzello G; Poggi G; Spreafico F; Peretta P; Mascarin M; Modena P; Sozzi G; Bedini N; Biassoni V; Urgesi A; Balestrini MR; Finocchiaro G; Sandri A; Gandola L;
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1440-5. PubMed ID: 16863927
[TBL] [Abstract][Full Text] [Related]
11. A multicenter study of the prognosis and treatment of adult brain ependymal tumors.
Reni M; Brandes AA; Vavassori V; Cavallo G; Casagrande F; Vastola F; Magli A; Franzin A; Basso U; Villa E
Cancer; 2004 Mar; 100(6):1221-9. PubMed ID: 15022290
[TBL] [Abstract][Full Text] [Related]
12. Childhood intracranial ependymoma: twenty-year experience from a single institution.
Shu HK; Sall WF; Maity A; Tochner ZA; Janss AJ; Belasco JB; Rorke-Adams LB; Phillips PC; Sutton LN; Fisher MJ
Cancer; 2007 Jul; 110(2):432-41. PubMed ID: 17559078
[TBL] [Abstract][Full Text] [Related]
13. Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.
Conter C; Carrie C; Bernier V; Geoffray A; Pagnier A; Gentet JC; Lellouch-Tubiana A; Chabaud S; Frappaz D
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1536-42. PubMed ID: 19362789
[TBL] [Abstract][Full Text] [Related]
14. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.
Massimino M; Gandola L; Barra S; Giangaspero F; Casali C; Potepan P; Di Rocco C; Nozza P; Collini P; Viscardi E; Bertin D; Biassoni V; Cama A; Milanaccio C; Modena P; Balter R; Tamburrini G; Peretta P; Mascarin M; Scarzello G; Fidani P; Milano GM; Sardi I; Genitori L; Garrè ML
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):807-14. PubMed ID: 20646868
[TBL] [Abstract][Full Text] [Related]
15. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.
Merchant TE; Jenkins JJ; Burger PC; Sanford RA; Sherwood SH; Jones-Wallace D; Heideman RL; Thompson SJ; Helton KJ; Kun LE
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):52-7. PubMed ID: 12007941
[TBL] [Abstract][Full Text] [Related]
16. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
Laithier V; Grill J; Le Deley MC; Ruchoux MM; Couanet D; Doz F; Pichon F; Rubie H; Frappaz D; Vannier JP; Babin-Boilletot A; Sariban E; Chastagner P; Zerah M; Raquin MA; Hartmann O; Kalifa C;
J Clin Oncol; 2003 Dec; 21(24):4572-8. PubMed ID: 14673044
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor.
Paulino AC; Cha DT; Barker JL; Lo S; Manera RB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1171-6. PubMed ID: 15001261
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
20. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
